Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

Investigator training: A three-day training course for clinical investigators on scientific, ethical and regulatory aspects of trials will be held Nov. 16-18 in Silver Spring, Md. (1"The Gray Sheet" May 11, 2009). The event is co-sponsored by FDA and the FDA/Duke University Clinical Trials Transformation Initiative. Participants must register at 2https://www.trialstransformation.org/course-registration by Nov. 2. Rachel Behrman, director of FDA's Office of Critical Path Programs, will run a session on FDA regulations and investigators' responsibilities in clinical trials. Cardiovascular Devices Division Director Bram Zuckerman will discuss clinical trial design issues for devices. Microbiology Devices Director Sally Hojvat will discuss diagnostic and combination product trial questions, according to a preliminary 3agenda
Advertisement

Related Content

Greater FDA Transparency Could Benefit Industry, Too, Trade Reps Say
Clinical investigation 101

Topics

Advertisement
UsernamePublicRestriction

Register

MT027828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel